Gastric acidity in patients with follicular gastritis is significantly reduced, but can be normalized after eradication for Helicobacter pylori

Helicobacter

Volumn 10, Issue 3, 2005, Pages 256-265

  Shimatani, Tomohiko ^a   Inoue, Masaki ^b   Iwamoto, Keiko ^a   Hyogo, Hideyuki ^a   Yokozaki, Michiya ^a   Saeki, Toshinari ^a   Tazuma, Susumu ^a   Horikawa, Yoko ^c   Harada, Nobue ^d  

^a HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Medical Co Kouwakai Eastern Examination Center   (Japan)

^d Hiroshima Prefectural Univ   (Japan)

Author keywords

Follicular gastritis; Gastric acidity; Gastrin; Helicobacter pylori; Serum pepsinogens

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MONONUCLEAR CELL; NEUTROPHIL; NIGHT; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH PH;

ADULT; FEMALE; GASTRIC ACID; GASTRINS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; PEPSINOGENS; PYLORIC ANTRUM;

HELICOBACTER PYLORI;

EID: 20044385427     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2005.00318.x     Document Type: Article

References (50)

1. Ohtaki H, Ohtaki R. Follow up studies on chronic gastritis-clinical studies of miliary patterns that appear like goose flesh, gastroscopically. J Jpn Physicians Assoc 1991;5:22-6. (in Japanese).
2. De Giacomo C, Fiocca R, Villani L, Lisato L, Licardi G, Diegoli N, Donadini A, Maggiore G. Helicobacter pylori infection and chronic gastritis: clinical, serological, and histologic correlations in children treated with amoxicillin and colloidal bismuth subcitrate. J Pediatr Gastroenterol Nutr 1990;11:310-6.
3. Eastham EJ, Elliott TS, Berkeley D, Jones DM. Campylobacter pylori infection in children. J Infect 1988;16:77-9.
4. Bujanover Y, Konikoff F, Baratz M. Nodular gastritis and Helicobacter pylori. J Pediatr Gastroenterol Nutr 1990;11:41-4.
5. Hassall E, Dimmick JE. Unique features of Helicobacter pylori disease in children. Dig Dis Sci 1991;36:417-23.
6. Sbeih F, Abdullah A, Sullivan S, Merenkov Z. Antral nodularity, gastric lymphoid hyperplasia, and Helicobacter pylori in adults. J Clin Gastroenterol 1996;22:227-30.
7. Ladas SD, Rokkas T, Georgopoulos S, Kitsanta P, Liatsos C, Eustathiadou P, Karameris A, Spiliadi C, Raptis SA. Predictive factors and prevalence of follicular gastritis in adults with peptic ulcer and nonulcer dyspepsia. Dig Dis Sci 1999;44:1156-60.
8. Miyamoto M, Haruma K, Yoshihara M, Hiyama T, Sumioka M, Nishisaka T, Tanaka S, Chayama K. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig Dis Sci 2003;48:968-75.
9. Miyamoto M, Haruma K, Hiyama T, Kamada T, Masuda H, Shimamoto F, Inoue K, Chayama K. High incidence of B-cell monoclonality in follicular gastritis: a possible association between follicular gastritis and MALT lymphoma. Virchows Arch 2002;440:376-80.
10. Miyamoto M, Haruma K, Yoshihara M, Sumioka M, Nishisaka T, Tanaka S, Inoue K, Chayama K. Five cases of nodular gastritis and gastric cancer: a possible association between nodular gastritis and gastric cancer. Dig Liver Dis 2002;34:819-20.
11. El-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995;109:681-91.
12. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997;113:15-24.
13. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
14. Shimatani T, Inoue M, Horikawa Y, Kawai Y, Tao C, Kajiyama G, Nakamura M. H. pylori is a major risk factor in nocturnal intragastric pH elevation and the decrease of gastric acid secretion in old age. Digestion 1998;59:249.
15. Maghidman S, Cok J, Bussalleu A. Findings in nodular gastritis. Experience at the Cayetano Heredia National Hospital. Rev Gastroenterol Peru 2001;21:261-70. (in Spanish).
16. Dixon MF. Campylobacter pylori and chronic gastritis. In: Rathbone BJ, Heatley RV, eds. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific. 1989; 106-16.
17. Mooney C, Keenan J, Munster D, Wilson I, Allardyce R, Bagshaw P, Chapman B, Chadwick V. Neutrophil activation by Helicobacter pylori. Gut 1991;32:853-7.
18. Samloff IM. Pepsinogens I and II. Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1981;82:26-33.
19. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
20. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41.
21. Haruma K, Yoshihara M, Sumii K, Tari A, Watanabe C, Kodoi A, Kajiyama G. Gastric acid secretion, serum pepsinogen I, and serum gastrin in Japanese with gastric hyperplastic polyps or polypoid-type early gastric carcinoma. Scand J Gastroenterol 1993;28:633-7.
22. Shimatani T, Inoue M, Horikawa Y, Kawai Y, Tao C, Kajiyama G. PH3 holding time correlates with serum pepsinogen I/II ratio in patients with Helicobacter pylori positive atrophic gastritis. Gastroenterology 1998;114:A286.
23. Mihara M, Haruma K, Kamada T, Komoto K, Yoshihara M, Sumii K, Kajiyama G. The role of endoscopic findings for the diagnosis of Helicobacter pylori infection: evaluation in a country with high prevalence of atrophic gastritis. Helicobacter 1999;4:40-8.
24. Kiyohira K, Yoshihara M, Ito M, Haruma K, Tanaka S, Chayama K. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels. J Gastroenterol 2003;38:332-8.
25. Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I. A multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91.
26. Beales IL, Post L, Calam J, Yamada T, Delvalle J. Tumour necrosis factor alpha stimulates gastrin release from canine and human antral G cells, possible mechanism of the Helicobacter pylori-gastrin link. Eur J Clin Invest 1996;26:609-11.
27. Prinz C, Neumayer N, Mahr S, Classen M, Schepp W. Functional impairment of rat enterochromaffin-like cells by interleukin 1 beta. Gastroenterology 1997;112:364-75.
28. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47.
29. Calam J, Baron JH. ABC of the upper gastrointestinal tract: pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ 2001;323: 980-2.
30. Zhao CM, Wang X, Friis-Hansen L, Waldum HL, Halgunset J, Wadstrom T, Chen D. Chronic Helicobacter pylori infection results in gastric hypoacidity and hypergastrinemia in wild-type mice but vagally induced hypersecretion in gastrin-deficient mice. Regul Pept 2003;115:161-70.
31. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997;32:664-8.
32. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Miyazaki Y, Murayama Y, Bonilla-Palacios JJ, Matsuzawa Y. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994;35:1571-4.
33. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, Shimosegawa T, Toyota T. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000;46:20-6.
34. Annibale B, Aprile MR, D'ambra G, Caruana P, Bordi C, Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000;14:625-34.
35. Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther 2004;19:1181-8.
36. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998;42:227-34.
37. Zhao CM, Chen D, Andersson K, Hakanson R. ECL cells of the rat stomach: development of lipofuscin in response to sustained gastrin stimulation. Cell Tissue Res 1998;291:315-23.
38. Xiao F, Furuta T, Takashima M, Shirai N, Hamai H. Effects of cyclooxygenase-2 inhibitor on gastric acid secretion in Helicobacter pylori-infected C57BL/6 mice. Scand J Gastroenterol 2001;36: 577-83.
39. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
40. Chowers MY, Keller N, Tal R, Barshack I, Lang R, Bar-Meir S, Chowers Y. Human gastrin: a Helicobacter pylori - specific growth factor. Gastroenterology 1999;117:1113-8.
41. Logan RP, Walker MM, Misiewicz JJ, Gummett PA, Karim QN, Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-6.
42. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334:1018-22.
43. Waldum HL, Brenna E, Sandvik AK. Relationship of ECL cells and gastric neoplasia. Yale J Biol Med 1998;71:325-35.
44. Hirschowitz BI, Haber MM. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. Aliment Pharmacol Ther 2001;15:87-103.
45. Chen D, Hakanson R. Mechanism of gastric ECL-cell tumor induction: observations in the rat. IARC Technical Publications, 2003;39:121-31.
46. Grossman MI, Kirsner JB, Gillespie IE. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 1963;45:14-26.
47. El-Omar EM, Carrington M, Chow WH, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001;412:99.
48. IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, 7-14 June 1994, IARC Monogr Eval Carcinog Risks Hum 1994;61:1-241.
49. Komoto K, Haruma K, Kamada T, Tanaka S, Yoshihara M, Sumii K, Kajiyama G, Talley NJ. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998;93:1271-6.
50. Haruma K, Komoto K, Kamada Ito M, Kitadai Y, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients. Scand J Gastroenterol 2000;35:255-9.